1. Fabrication of mesoporous silica nanoparticles for targeted delivery of sunitinib to ovarian cancer cells

Mitra Torabi , Ayuob Aghanejad*, Pouria Savadi , Abolfazl Barzegari, Yadollah Omidi , Jaleh Barar*

Bioimpacts. 2023;13(3): 255-267. doi: 10.34172/bi.2023.25298

PMCID: PMC10329750 PMID: 37431477 Scopus ID: 85158830047

Article

PDF

Full Text

XML

Cited By:

Owing to their unique advantages, mesoporous silica nanoparticles (MSNPs) have attracted much attention for drug delivery and targeting. In the current study, MSNPs were fabricated, PEGylated, loaded with sunitinib, and conjugated with mucin-16 aptamer to target CA125 on ovarian cancer cells.

Original Article

2. Synthesis and functionalization of mucoadhesive mesoporous silica particles containing diphenhydramine for treatment of aphthous ulcers

Azadeh Vaezi Moghaddam , Seyed Alireza Mortazavi* , Farzad Kobarfard, Reza Bafkary, Behzad Darbasizadeh

Bioimpacts. 2023;13(6): 456-466. doi: 10.34172/bi.2023.27548

PMCID: PMC10676526 PMID: 38022378

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons